Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Practice Operations · For practice managers

Texas Medical Device Distributor Licensing & Biologics

Published November 20, 2026

Regulatory Oversight Layers
Dual (State & Federal)

Texas practices must verify state DSHS medical device licensing alongside federal FDA 21 CFR Part 1271 tissue registrations.

DRS Texas DSHS License
#1002308

Dallas Regenerative Solutions has operated as a licensed Texas medical device distributor since 2016.

Traceability Requirement
100% Lot-to-Patient

Compliant biologics workflow requires unbroken documentation from the originating tissue bank through cold-chain transit to the patient chart.

In Texas, medical device distributor licensing requirements for biologics involve dual-layer regulatory oversight: state-level registration through the Texas Department of State Health Services (DSHS) for medical devices and kits, alongside federal FDA registration under 21 CFR Part 1271 for human cells, tissues, and cellular and tissue-based products (HCT/Ps). Because regenerative medicine lines frequently combine point-of-care medical devices (such as PRP centrifuge systems) with cellular allografts, a compliant distributor must maintain an active Texas DSHS Wholesale Medical Device Distributor license and verifiable tissue bank partnerships. Practice administrators should verify both credentials before onboarding any regenerative vendor to protect clinic liability and ensure unbroken cold-chain custody.

The Dual Regulatory Framework: Devices vs. Biologics

For a medical practice manager or clinic administrator, procurement in the regenerative space can appear fragmented. A single treatment protocol may involve a mechanical separation kit, an energy-based delivery modality, and a cryopreserved allograft. Regulatory bodies do not view these items under a single umbrella, which means your vendor vetting process must account for both state and federal classifications.

State Oversight: Texas DSHS Medical Device Distribution

The Texas Department of State Health Services (DSHS) regulates the manufacture and wholesale distribution of medical devices within the state under Title 25 of the Texas Administrative Code. Any vendor supplying your clinic with medical devices—whether that is a Platelet-Rich Plasma (PRP) preparation system, a shockwave therapy unit, or a specialized laser like the Eufoton Lasemar 1500—must hold an active Texas Medical Device Distributor license.

For example, Dallas Regenerative Solutions operates under Texas medical device distributor license #1002308, having maintained compliance since our founding in 2016. This state-level licensure mandates that the distributor adheres to strict facility standards, maintains accurate distribution records for potential recall traceability, and restricts sales exclusively to licensed healthcare practitioners or authorized medical facilities.

Federal Oversight: FDA 21 CFR Part 1271 for HCT/Ps

When your procurement shifts from hardware and blood-separation kits to human allografts—such as Wharton’s Jelly, amniotic tissue matrices, cord blood, or MSC exosomes—oversight transitions heavily toward the federal level. The Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps) under 21 CFR Part 1271.

Distributors supplying biologics in Texas must ensure that every tissue product originates from an FDA-registered tissue establishment that follows Current Good Tissue Practice (CGTP). Furthermore, if a facility processes, stores, or distributes human tissue for transplantation, they must meet specific donor eligibility, infectious disease screening, and labeling standards. While Texas DSHS oversees device distribution, the integrity of the biologic itself relies on continuous adherence to federal HCT/P statutes and accreditation standards, such as those set by the American Association of Tissue Banks (AATB).

Where Devices and Biologics Intersect in Practice Operations

Understanding the distinction between a device and a biologic is critical for inventory management, billing, and compliance logs.

Consider Platelet-Rich Plasma (PRP). While the end product injected by the physician is an autologous biologic derived from the patient's own blood, the tubes, anticoagulants, and centrifuges purchased by the practice are regulated as medical devices. These require a 510(k) clearance from the FDA and must be sourced through a licensed medical device distributor.

Conversely, off-the-shelf homologous products require cold-chain logistics, donor lot tracking, and tissue implantation logs. When a distributor provides both regenerative technologies and cellular products, they bridge two distinct regulatory frameworks. Relying on an unlicensed broker or an out-of-state entity that fails to register with Texas DSHS exposes the medical practice to supply chain disruptions, confiscated shipments, and malpractice vulnerabilities.

Vendor Compliance Checklist for Practice Managers

Before signing a purchasing agreement or onboarding a new supplier for your clinic, administrators should request a standardized compliance packet. Use the following checklist to audit potential distribution partners:

  • Active Texas DSHS License Number: Verify that the distributor holds a current Wholesale Distributor of Medical Devices license with the Texas Department of State Health Services. Ask for the license number and confirm its active status.
  • FDA Establishment Registration (FEI) Verification: For any allografts or HCT/Ps, require the FDA registration certificate of the processing laboratory or tissue bank.
  • AATB Accreditation Documentation: While voluntary, accreditation by the American Association of Tissue Banks is the clinical gold standard for donor screening and tissue processing safety.
  • 510(k) Clearance Letters: For point-of-care autologous systems (like PRP or bone marrow aspirate concentration kits) and capital equipment, keep copies of the FDA 510(k) clearance letters in your clinic's compliance binder.
  • Cold-Chain Validation Protocols: Ensure the vendor uses validated cryogenic or temperature-controlled shipping containers and provides clear SOPs for transferring biologics into your clinic's on-site storage.
  • Lot Number and Recall Traceability: Confirm that the vendor's invoicing and packing slips clearly document lot numbers, expiration dates, and donor identification codes to satisfy your internal tissue tracking logs.
  • Physician Credentialing Verification: A compliant distributor will never sell prescription devices or biologics without first verifying the active medical license (MD, DO, DPM, etc.) and DEA/NPI credentials of the supervising clinician.

Operational Workflow: Managing Risk and Cold-Chain Custody

From an operational standpoint, compliance does not end when the delivery courier hands over the package. Practice managers are responsible for establishing internal standard operating procedures (SOPs) that mirror the distributor's compliance standards.

First, designate a specific clinical staff member to handle biologics intake. When an allograft shipment arrives, staff must inspect the dry ice or phase-change material immediately to verify that no temperature excursion occurred during transit. If a distributor cannot prove validated shipping timelines, the viability of the cellular or acellular matrix is compromised, directly impacting your cost per treatment and clinical outcomes.

Second, maintain a centralized tissue log. Every biologic unit received should be logged with its unique identifier, date of receipt, storage temperature, date of clinical application, and the patient chart number. Should a tissue bank ever issue a market withdrawal or safety notice, your practice must be able to identify the exact recipient within minutes.

For the Treating Clinician: Why Supply Chain Compliance Protects Your License

While practice administrators generally manage vendor vetting and procurement workflows, the ultimate regulatory and liability burden rests on the medical license of the treating physician. For doctors across specialties—including orthopedics, pain management, aesthetics, and integrative medicine—sourcing from an improperly licensed vendor introduces severe clinical and legal risks.

When a physician administers a biologic or utilizes a medical device, state medical boards expect the clinician to know the regulatory status of the product entering the patient's body. Utilizing unverified gray-market tubes for blood separation, or purchasing allografts from brokers who cannot provide complete donor eligibility records and infectious disease screening panels (such as HIV, Hepatitis B/C, and Syphilis testing), can lead to adverse patient events, infection clusters, and board disciplinary action.

Furthermore, clinical efficacy depends entirely on handling standards. Growth factors, cytokines, and extracellular vesicles degrade rapidly if subjected to improper freeze-thaw cycles in an unregulated warehouse. Partnering with an established, licensed distributor ensures that the materials you rely on for tissue remodeling and patient recovery retain their structural and biological integrity from the laboratory to the treatment room.

What This Means for Your Practice

Ensuring your clinic meets Texas regulatory expectations does not require overhauling your daily schedule, provided you standardize your procurement rules. Take these concrete next steps to secure your regenerative service line:

  1. Audit Your Current Vendors: Review the invoices and onboarding files of every supplier currently providing your clinic with PRP kits, allografts, lasers, or shockwave devices. Ensure you have their Texas DSHS license number and FDA tissue bank registrations on file.
  2. Centralize Your Compliance Binder: Create a physical or digital repository containing 510(k) clearances, tissue bank certificates, and device maintenance logs so your practice is perpetually inspection-ready.
  3. Standardize Receiving SOPs: Train your medical assistants and front-desk receivers on how to inspect cold-chain packaging and log lot numbers immediately upon delivery.
  4. Consolidate Your Supply Chain: Reduce administrative overhead by working with a single, verified distributor capable of supplying compliant biologics, capital equipment, and everyday clinical supplies.

If you are evaluating your current supply chain or adding new regenerative modalities to your clinic, our team can help you navigate product selection, staff workflow, and compliance documentation. Reach out to Dallas Regenerative Solutions via our contact page to schedule a practice consultation and review our credentialed portfolio.

Frequently asked questions

What license is required to distribute medical devices in Texas?
To legally distribute medical devices in Texas, a company must hold an active Wholesale Distributor of Medical Devices license issued by the Texas Department of State Health Services (DSHS). This license requires the distributor to pass facility inspections, maintain strict record-keeping for lot traceability, and sell exclusively to licensed healthcare professionals or authorized medical facilities.
How does the FDA regulate biologics and allografts differently from medical devices?
Medical devices, including point-of-care PRP preparation kits and therapeutic lasers, are regulated by the FDA Center for Devices and Radiological Health (CDRH) and typically require 510(k) clearance. Biologics and human tissue allografts (HCT/Ps) are regulated by the Center for Biologics Evaluation and Research (CBER) under 21 CFR Part 1271, which mandates donor eligibility screening, infectious disease testing, and Current Good Tissue Practice (CGTP).
How can a practice manager verify a regenerative vendor's compliance?
Practice managers should request a vendor's Texas DSHS medical device distributor license number, copies of FDA 510(k) clearance letters for devices, and current FDA Establishment Registration certificates for any partner tissue banks. Additionally, administrators should verify whether the source tissue banks hold accreditation from the American Association of Tissue Banks (AATB).
Do PRP kits require a biologics license or a medical device license to distribute?
Although Platelet-Rich Plasma (PRP) is an autologous biological therapy, the collection tubes, separating gels, and centrifuges used to prepare it at the point of care are classified and regulated by the FDA as medical devices. Therefore, the vendor supplying your clinic with PRP kits must be licensed as a medical device distributor and provide systems with appropriate FDA 510(k) clearance.
What records must a Texas medical practice keep when receiving human allografts?
Clinics should maintain a comprehensive tissue tracking log that records the distributor's name, the source tissue bank, the unique donor or lot identification number, the expiration date, the date of receipt, and verification of intact cold-chain shipping. Once administered, the specific lot number must be linked directly to the receiving patient's medical record to ensure complete traceability.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →